MUCOLYTIC THERAPY IN INFANTS

Abstract

When prescribing mucolytic therapy for bronchopulmonary diseases to infants, it is necessary to consider not only peculiarities of a small child’s respiratory tract, but also action of mucolytic drugs. The authors exemplify their data on efficacy and safety of the use of mucolytics in children under 2 years of age with acetylcysteine.

Keywords

• frequently ill children
• acute respiratory infections
• mucociliary clearance
• bronchoobstructive syndrome
• acute bronchitis
• recurrent bronchitis
• bronchopulmonary dysplasia
• acetylcysteine
• external respiration function